Ultrastructural changes in the masseter muscle of Macaca fascicularis resulting from intramuscular injections of botulinum toxin type A.
Intramuscular injections of botulinum toxin type A (Oculinum) is used to treat strabismus and focal dystonias affecting orofacial muscles. However, the toxin-induced morphological changes that underlie the therapeutic alterations of tone in the muscles of mastication have not been described. In this study, paired intramuscular injections of botulinum toxin (10 units) were made in three adult monkeys (Macaca fascicularis) allowed to survive 14, 28 and 63 days. Another monkey received multiple injection-pairs over 84 days. Animals were killed by deep pentobarbital anaesthesia before transcardiac perfusion-fixation. Tissue sampled from comparable regions of the injected masseter, the uninjected masseter and an uninjected animal was processed for ultrastructural analysis. Few changes were found 14 days post-injection. However, muscle fibres showed myofibrillar dissolution, aberrations in the Z-line, and enlarged mitochondria in the region of the I-band by 28 days. In the 63-day and 84-day animals, the injected muscle was considerably smaller than the uninjected, contralateral muscle. Regions of the injected muscle contained fibres with markedly reduced cross-sectional area. Internalization of myonuclei, loss of myofibrillar organization, and helical complexes were common. Toxin-induced changes, though similar to those that follow denervation by axotomy, were not accompanied by degeneration of neuromuscular junctions. Instead, morphological evidence for axonal sprouting in the region of the neuromuscular junction, possibly contributing to functional recovery, was seen as early as 14 days in toxin-treated muscles.
Capra
N F
NF
Department of Physiology, University of Maryland Dental School, Baltimore 21201.
Bernanke
J M
JM
Porter
J D
JD
D008841:Actin Cytoskeleton / Q000648:ultrastructure; D000818:Animals; D001284:Atrophy; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000494:pharmacology*; D002467:Cell Nucleus / Q000648:ultrastructure; D003238:Connective Tissue / Q000648:ultrastructure; D007273:Injections, Intramuscular; D008252:Macaca fascicularis; D008406:Masseter Muscle / Q000473:pathology / Q000648:ultrastructure*; D008870:Microtubules / Q000648:ultrastructure; D009210:Myofibrils / Q000648:ultrastructure; D009469:Neuromuscular Junction / Q000648:ultrastructure; D012508:Sarcolemma / Q000648:ultrastructure; D012518:Sarcomeres / Q000648:ultrastructure; D013997:Time Factors
D001905:Botulinum Toxins